STO: SUS Statistics

Total Valuation

Surgical Science Sweden AB has a market cap or net worth of SEK 8.24 billion. The enterprise value is 7.57 billion.

Market Cap	8.24B
Enterprise Value	7.57B

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	n/a

Share Statistics

Surgical Science Sweden AB has 51.03 million shares outstanding. The number of shares has increased by 0.26% in one year.

Current Share Class	n/a
Shares Outstanding	51.03M
Shares Change (YoY)	+0.26%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.64%
Owned by Institutions (%)	53.03%
Float	37.43M

Valuation Ratios

The trailing PE ratio is 42.63 and the forward PE ratio is 36.02.

PE Ratio	42.63
Forward PE	36.02
PS Ratio	9.58
PB Ratio	1.85
P/TBV Ratio	10.04
P/FCF Ratio	74.19
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 40.68, with an EV/FCF ratio of 68.19.

EV / Earnings	39.18
EV / Sales	8.81
EV / EBITDA	40.68
EV / EBIT	52.24
EV / FCF	68.19

Financial Position

The company has a current ratio of 4.44

Current Ratio	4.44
Quick Ratio	3.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 4.31% and return on invested capital (ROIC) is 2.02%.

Return on Equity (ROE)	4.31%
Return on Assets (ROA)	1.86%
Return on Capital (ROIC)	2.02%
Revenue Per Employee	3.18M
Profits Per Employee	716,085
Employee Count	260
Asset Turnover	0.18
Inventory Turnover	1.56

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.37% in the last 52 weeks. The beta is 0.98, so Surgical Science Sweden AB's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-9.37%
50-Day Moving Average	138.16
200-Day Moving Average	135.56
Relative Strength Index (RSI)	71.59
Average Volume (20 Days)	91,883

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Surgical Science Sweden AB had revenue of SEK 859.83 million and earned 193.34 million in profits. Earnings per share was 3.79.

Revenue	859.83M
Gross Profit	590.25M
Operating Income	144.98M
Pretax Income	237.11M
Net Income	193.34M
EBITDA	171.28M
EBIT	144.98M
Earnings Per Share (EPS)	3.79

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	666.33M
Total Debt	n/a
Net Cash	666.33M
Net Cash Per Share	13.06
Equity (Book Value)	4.45B
Book Value Per Share	87.19
Working Capital	838.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 120.15 million and capital expenditures -9.08 million, giving a free cash flow of 111.07 million.

Operating Cash Flow	120.15M
Capital Expenditures	-9.08M
Free Cash Flow	111.07M
FCF Per Share	2.18

Full Cash Flow Statement

Margins

Gross margin is 68.65%, with operating and profit margins of 16.86% and 22.49%.

Gross Margin	68.65%
Operating Margin	16.86%
Pretax Margin	27.58%
Profit Margin	22.49%
EBITDA Margin	19.92%
EBIT Margin	16.86%
FCF Margin	12.92%

Dividends & Yields

Surgical Science Sweden AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.26%
Shareholder Yield	-0.26%
Earnings Yield	2.35%
FCF Yield	1.35%

Dividend Details

Stock Splits

The last stock split was on May 25, 2020. It was a forward split with a ratio of 5.

Last Split Date	May 25, 2020
Split Type	Forward
Split Ratio	5

Scores

Surgical Science Sweden AB has an Altman Z-Score of 13.37.

Altman Z-Score	13.37
Piotroski F-Score	n/a